Ms Andrea Reid > Dechert LLP > Boston, United States > Lawyer Profile

Dechert LLP is well-placed to advise clients engaged in major cross-border transactions, including assisting with patent strategies tied to deals. On the contentious front, the firm’s litigators represent clients in patent disputes tied to a variety of drugs, and are also well versed in handling MDLs and class actions arising out of product liability claims. Boston-based patent specialist Andrea Reid advises biotech and pharmaceutical clients on the management of their IP portfolios, offering a deep understanding of the drug discovery and development processes and leading the practice alongside New York’s David Rosenthal, who advises life sciences-focused investors on IPOs, secondary offerings and licensing matters. Also based in New York, litigator Katherine Helm handles a broad spectrum of patent-related disputes, representing both plaintiffs and defendants in infringement suits and tackling commercial issues including breach of contract and antitrust litigations.

Dechert LLP‘s Boston-based patent prosecution team is well-known for its capabilities in all patent prosecution matters as well as in portfolio management for its clients. The team’s workload includes advising on IP due diligence and negotiations, and on the sale and acquisition of patent portfolios. The cases are often of considerable value and vary between domestic and international in scope. The life sciences industry is the team’s key focus area and it also has an increasing focus on biologics. The team heads Andrea Reid and Andrew Wilkins are described as being ‘very experienced, engaged and responsive lead partners’, with key attorney to note in the team being Chad Davis.